CKD: DBP variability tied to worse CV outcomes, hypoperfusion events

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Diastolic BP (DBP) variability predicts major cardiovascular (CV) and hypoperfusion-related adverse events in patients with chronic kidney disease (CKD) who meet BP goals.

 Why this matters

  • Limited data suggests less BP variability with calcium channel blockers and higher ...